Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A multicenter study of the real-world use of ceftaroline versus vancomycin for acute bacterial skin and skin structure infections.

Trinh TD, Jorgensen SCJ, Zasowski EJ, Claeys KC, Lagnf AM, Estrada SJ, Delaportes DJ, Huang V, Klinker KP, Kaye KS, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01007-19. doi: 10.1128/AAC.01007-19. [Epub ahead of print]

PMID:
31405859
2.

Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study.

Jorgensen SCJ, Zasowski EJ, Trinh TD, Lagnf AM, Bhatia S, Sabagha N, Abdul-Mutakabbir JC, Alosaimy S, Mynatt RP, Davis SL, Rybak MJ.

Clin Infect Dis. 2019 Aug 12. pii: ciz746. doi: 10.1093/cid/ciz746. [Epub ahead of print]

PMID:
31404468
3.

The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Treated With Vancomycin.

Zasowski EJ, Trinh TD, Atwan SM, Merzlyakova M, Langf AM, Bhatia S, Rybak MJ.

Open Forum Infect Dis. 2019 Feb 27;6(7):ofz077. doi: 10.1093/ofid/ofz077. eCollection 2019 Jul.

4.

Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP.

Int J Antimicrob Agents. 2019 Sep;54(3):346-350. doi: 10.1016/j.ijantimicag.2019.07.002. Epub 2019 Jul 5.

PMID:
31284042
5.

The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Treated With Vancomycin.

Zasowski EJ, Trinh TD, Atwan SM, Merzlyakova M, Langf AM, Bhatia S, Rybak MJ.

Open Forum Infect Dis. 2019 Apr 3;6(4):ofz079. doi: 10.1093/ofid/ofz079. eCollection 2019 Apr. Retraction in: Open Forum Infect Dis. 2019 Feb 27;6(7):ofz077.

6.

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus.

Claeys KC, Zasowski EJ, Trinh TD, Casapao AM, Pogue JM, Bhatia N, Mynatt RP, Wilson SS, Arthur C, Welch R, Sherwin R, Hafeez W, Levine DP, Kaye KS, Delgado G, Giuliano CA, Takla R, Rieck C, Johnson LB, Murray KP, Gordon J, Reyes K, Hartman P, Davis SL, Rybak MJ.

Infect Dis Ther. 2019 Jun;8(2):199-208. doi: 10.1007/s40121-019-0242-5. Epub 2019 Mar 27.

7.

Reply to Cheng and Chuang.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP.

Clin Infect Dis. 2019 Aug 16;69(5):903-904. doi: 10.1093/cid/ciz081. No abstract available.

PMID:
30715199
8.

Risk Factors for Bloodstream Infections Among an Urban Population with Skin and Soft Tissue Infections: A Retrospective Unmatched Case-Control Study.

Rybak MJ, Zasowski EJ, Jorgensen SCJ, Lagnf AM, Davis SL, Mendelsohn AB, Margaritis V.

Infect Dis Ther. 2019 Mar;8(1):75-85. doi: 10.1007/s40121-018-0227-9. Epub 2018 Dec 18.

9.

Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting.

Claeys KC, Zasowski EJ, Lagnf AM, Sabagha N, Levine DP, Davis SL, Rybak MJ.

Infect Dis Ther. 2018 Dec;7(4):495-507. doi: 10.1007/s40121-018-0212-3. Epub 2018 Sep 22.

10.

Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP.

Clin Infect Dis. 2019 May 2;68(10):1650-1657. doi: 10.1093/cid/ciy749.

PMID:
30188976
11.

The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in Therapy.

Zasowski EJ, Lodise TP.

J Clin Pharmacol. 2018 Sep;58(9):1131-1133. doi: 10.1002/jcph.1281. Epub 2018 Jul 19. No abstract available.

PMID:
30024648
12.

Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus Infections.

Trinh TD, Zasowski EJ, Claeys KC, Casapao AM, Compton M, Lagnf A, Kidambi SD, Levine DP, Rybak MJ.

Infect Dis Ther. 2018 Mar;7(1):161-169. doi: 10.1007/s40121-018-0187-0. Epub 2018 Feb 22.

13.

Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis.

Claeys KC, Zasowski EJ, Trinh TD, Lagnf AM, Davis SL, Rybak MJ.

Infect Dis Ther. 2018 Mar;7(1):135-146. doi: 10.1007/s40121-017-0179-5. Epub 2017 Nov 21.

14.

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.

Zasowski EJ, Murray KP, Trinh TD, Finch NA, Pogue JM, Mynatt RP, Rybak MJ.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01684-17. doi: 10.1128/AAC.01684-17. Print 2018 Jan.

15.

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.

Finch NA, Zasowski EJ, Murray KP, Mynatt RP, Zhao JJ, Yost R, Pogue JM, Rybak MJ.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01293-17. doi: 10.1128/AAC.01293-17. Print 2017 Dec.

16.

Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors.

Trinh TD, Zasowski EJ, Claeys KC, Lagnf AM, Kidambi S, Davis SL, Rybak MJ.

Diagn Microbiol Infect Dis. 2017 Sep;89(1):61-66. doi: 10.1016/j.diagmicrobio.2017.06.009. Epub 2017 Jun 19.

PMID:
28716451
17.

Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infections.

Claeys KC, Zasowski EJ, Lagnf AM, Levine DP, Davis SL, Rybak MJ.

Int J Antimicrob Agents. 2018 Jan;51(1):43-46. doi: 10.1016/j.ijantimicag.2017.05.015. Epub 2017 Jun 28.

PMID:
28668679
18.

Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, Sabagha N, Lagnf AM, Klinker KP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02015-16. doi: 10.1128/AAC.02015-16. Print 2017 Feb.

19.

Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct.

20.

Characterization of the haematological profile of 21 days of tedizolid in healthy subjects.

Lodise TP, Bidell MR, Flanagan SD, Zasowski EJ, Minassian SL, Prokocimer P.

J Antimicrob Chemother. 2016 Sep;71(9):2553-8. doi: 10.1093/jac/dkw206. Epub 2016 Jun 17.

PMID:
27317442
21.

Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infections.

Lagnf AM, Zasowski EJ, Claeys KC, Casapao AM, Rybak MJ.

Am J Infect Control. 2016 Aug 1;44(8):917-21. doi: 10.1016/j.ajic.2016.02.017. Epub 2016 Apr 11.

PMID:
27079241
22.

Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.

Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ.

Clin Infect Dis. 2016 May 15;62(10):1242-1250. doi: 10.1093/cid/ciw110. Epub 2016 Mar 3.

23.

Comparison of outcomes between patients with single versus multiple positive blood cultures for Enterococcus: Infection versus illusion?

Claeys KC, Zasowski EJ, Lagnf AM, Rybak MJ.

Am J Infect Control. 2016 Jan 1;44(1):47-9. doi: 10.1016/j.ajic.2015.08.002. Epub 2015 Sep 19.

PMID:
26388037
24.

The β-Lactams Strike Back: Ceftazidime-Avibactam.

Zasowski EJ, Rybak JM, Rybak MJ.

Pharmacotherapy. 2015 Aug;35(8):755-70. doi: 10.1002/phar.1622. Review.

25.

Reevaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysis.

Cardone KE, Grabe DW, Zasowski EJ, Lodise TP.

Antimicrob Agents Chemother. 2014;58(1):19-26. doi: 10.1128/AAC.00873-13. Epub 2013 Oct 14.

Supplemental Content

Loading ...
Support Center